[1] HU J,YE M,ZHOU Z. Aptamers:novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases[J].J Mol Med (Berl),2017,95(3):249-256.
[2] KOLLER L,HOHENSINNER P,SULZGRUBER P,et al. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure[J].Thromb Haemostasis,2016,116(2):309-316.
[3] JOLADARASHI D,THANDAVARAYAN R A,SURESH BABU S,et al. Abstract 204:serine threonine kinase-35 regulates diabetes-induced endothelial progenitor cells dysfunction[J].Circ Res,2016,119(Suppl 1):A204-206.
[4] YU J W,DENG Y P,HAN X,et al. Metfor min improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice[J].Cardiovasc Diabetol,2016,15(1):88.
[5] SKORTSOVA K,TABERLAY P,CLARK S J. Role of 5-hydroxymethylation and TET enzymes in remodelling the epigenome[J].Exp Med,2016,34:1-9.
[6] KO M,AN J,PASTOR W A,et al. TET proteins and 5-methylcytosine oxidation in hematological cancers[J].Immunol Rev,2015,263(1):6-21.
[7] GROSS J A,PACIS A,CHEN G G,et al. Characterizing 5-hydroxymethylcytosine in human prefrontal cortex at single base resolution[J].BMC Genomics,2015,16:672.
[8] WU Y,DING Y,TANAKA Y,et al. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention[J].Int J Med Sci,2014,11(11):1185-2000.
[9] SMITH C J,RYCKMAN K K. Epigenetic and developmental influences on the risk of obesity,diabetes,and metabolic syndrome[J].Diabetes Metab Syndr Obes,2015,8:295-302.
[10] 陈光照,杨柳青,文娟,等.液相色谱-串联质谱法分析大鼠血液中基因组DNA羟甲基化水平[J].质谱学报,2015(36):249-254.
[11] ZHANG L T,ZHANG L J,ZHANG J J,et al. Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line[J].Bioanalysis,2013,5(7):839-845.
[12] WANG C,YE Y,SUN W,et al. Red blood cells for glucose-responsive insulin delivery[J/OL].Adv Mater,2017,29(18).doi:10.1002/adma.201606617.
[13] 王瑜,乔虹. DNA甲基化与2型糖尿病的研究进展[J].哈尔滨医科大学学报,2015(3):276-278.
[14] ZHANG M,MALIK A B,REHMAN J. Endothelial progenitor cells and vascular repair[J].Curr Opin Hematol,2014,21(3):224-228.
[15] BITTERLI L,AFAN S,BVHLER S,et al. Endothelial progenitor cells as a biological marker of peripheral artery disease[J].Vasc Med,2015,21(1):3-11.
[16] DELGADO-CRUZATA L,WU H C,SHEN J,et al. Abstract 4439:relationship between DNA methylation of TET genes and levels of 5-methyl-cytosine and 5-hydroxymethyl-cytosine in hepatocellular carcinoma[J].Cancer Res,2016,76(14 Supplement):4439-4443.
[17] KROEZE L I,VAN DER REIJDEN B A,JANSEN J H. 5-hydroxymethylcytosine:an epigenetic mark frequently deregulated in cancer[J].Biochim Biophys Acta,2015,1855(2):144-154.
[18] 陈晓颖,叶华丹,洪青晓,等.DNA甲基化修饰对血管疾病稳态失衡的影响[J].遗传,2015(3):221-232.
[19] WEN L,LI X,YAN L,et al. Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain[J].Genome Biol,2014,15(3):R49. |